ArticleBMC cancer2025

Lenvatinib combined with anti-PD-1 antibodies plus locoregional treatment for initial unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a multicenter real-world study.

Qi-Yu Chi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.